Browse > Article

The neuroprotective effect of mycophenolic acid via anti-apoptosis in perinatal hypoxic-ischemic brain injury  

Kim, Ji Young (Department of Pediatrics, School of Medicine, Catholic University of Daegu)
Yang, Seung Ho (Department of Pediatrics, School of Medicine, Catholic University of Daegu)
Cha, Sun Hwa (Department of Pediatrics, School of Medicine, Catholic University of Daegu)
Kim, Ji Yeun (Department of Neurology, School of Medicine, Catholic University of Daegu)
Jang, Young Chae (Department of Pathology, School of Medicine, Catholic University of Daegu)
Park, Kwan Kyu (Department of Pathology, School of Medicine, Catholic University of Daegu)
Kim, Jin Kyung (Department of Pediatrics, School of Medicine, Catholic University of Daegu)
Chung, Hai Lee (Department of Pediatrics, School of Medicine, Catholic University of Daegu)
Seo, Eok Su (Department of Opthalmology, College of Medicine, Dongguk University)
Kim, Woo Taek (Department of Pediatrics, School of Medicine, Catholic University of Daegu)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.7, 2007 , pp. 686-693 More about this Journal
Abstract
Purpose : Mycophenolic acid (MPA), the active metabolite of mycophenolate mofetil (MMF), is a potent inhibitor of inosine-monophosphate dehydrogenase (IMPDH), a new immunosuppressive drug used. It was reported that MPA protected neurons after excitotoxic injury, induced apoptosis in microglial cells. However, the effects of MPA on hypoxic-ischemic (HI) brain injury has not been yet evaluated. Therefore, we examined whether MPA could be neuroprotective in perinatal HI brain injury using Rice-Vannucci model (in vivo) and in rat brain cortical cell culture induced by hypoxia (in vitro). Methods : Cortical cells were cultured using a 18-day-pregnant Sprague-Dawley (SD) rats and incubated in 1% $O_2$ incubator for hypoxia. MPA ($10{\mu}g/mL$) before or after a HI insult was treated. Seven-day-old SD rat pups were subjected to left carotid occlusion followed by 2 hours of hypoxic exposure (8% $O_2$). MPA (10 mg/kg) before or after a HI insult were administrated intraperitoneally. Apoptosis was measured using western blot and real-time PCR for Bcl-2, Bax, caspase-3. Results : H&E stain revealed increased brain volume in the MPA-treated group in vivo animal model of neonatal HI brain injury. Western blot and real-time PCR showed the expression of caspase-3 and Bax/Bcl-2 were decreased in the MPA-treated group In in vitro and in vivo model of perinatal HI brain injury, Conclusion : These results may suggest that the administration of MPA before HI insult could significantly protect against perinatal HI brain injury via anti-apoptotic mechanisms, which offers the possibility of MPA application for the treatment of neonatal HI encephalopathy.
Keywords
Mycophenolic acid; Hypoxia-Ischemia; Apoptosis; Caspase-3; Bax; Bcl-2;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, et al. Rat model of perinatal hypoxicischemic brain damage. J Neurosci Res 1999;55:158-63   DOI   ScienceOn
2 Gunn AJ, Gunn TR. The 'pharmacology' of neuronal rescue with cerebral hypothermia. Early Hum Dev 1998;53:19-35   DOI   ScienceOn
3 Feng Y, Fratkin JD, LeBlanc MH. Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats. Eur J Pharmacol 2004;484:65-74   DOI   ScienceOn
4 Dehghani F, Hischebeth GT, Wirjatijasa F, Kohl A, Korf HW, Hailer NP. The immunosuppressant mycophenolate mofetil attenuates neuronal damage after excitotoxic injury in hippocampal slice cultures. Europ J Neuro 2003;18:1061- 72   DOI   ScienceOn
5 Daina E, Schieppati A, Remuzzi G. Mycophenolate mofetil for the treatment of takayasu arteritis: report of three cases. Ann Intern Med 1999;130:422-6   DOI   ScienceOn
6 Waiser J, Budde K, Braasch E, Neumayer HH. Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil. Am J Kidney Dis 1999;34:e9
7 Hu WX, Liu ZH, Chen HP, Tang Z, Li LS. Mycophenolate mofetil treatment for refractory severe lupus nephritis. J Nephrol Dialy Transplant 1998;7:511-4
8 Choi DW. Excitotoxic cell death. J Neurobiol 1992;23:1261-76   DOI
9 Williams RH, Lively DH, Delong DC, Cline JC, Sweeny MJ. Mycophenolic acid: antiviral and antitumor properties. J Antibiot(Tokyo) 1968;21:463-4   DOI
10 Carr SF, Papp E, Wu JC, Natsumeda Y. Characterization of human type I and type II IMP dehydrogenases. J Biol Chem 1993;268:27286-92
11 Mathieu P, Carrier M, White M, Pellerin M, Perrault L, Pelletier G, et al. Effect of mycophenolate mofetil in heart transplantation. Can J Surg 2000;43:202-6
12 Allison AC, Kowalski WJ, Muller CJ, Waters RV, Eugui EM. Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant Proc 1993;25:67-70
13 Cohn RG, Mirkovich A, Dunlap B, Burton P, Chiu SH, Eugui E, et al. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 1999;68:411-8   DOI   ScienceOn
14 Pardo-Mindan FJ, Errasti P, Panizo A, Lozano MD, de Alava E. Decrease of apoptosis rate in patients treated with mycophenolate mofetil. Nephron 1999;82:232-7   DOI   ScienceOn
15 Edwards AD, Yue X, Cox P, Hope PL, Azzopardi DV, Squier MV, et al. Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatr Res 1997;42:684-9   DOI   ScienceOn
16 Mitsui A, Suzuki S. Immunosuppressive effect of mycophenolic acid. J Antibiot 1969;22:358-63
17 Rice JE, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131-41   DOI   ScienceOn
18 Vannucci RC, Perlman JM. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatr 1997;100:1004-14   DOI   ScienceOn
19 Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult. PNS Development 1994;120:301-11
20 Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 1997;94:8830-5   DOI
21 Ota K, Yakovlev AG, Itaya A, Kameoka M, Tanaka Y, Yoshihara K. Alteration of apoptotic protease-activating factor-1 (APAF-1)-dependent apoptotic pathway during development of rat brain and liver. J Biochem 2002;131:131-5   DOI   ScienceOn
22 Langford CA, Talar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis. Rheum. 2004;51:278-83   DOI   ScienceOn
23 Thomas-Golbanov C, Sridharan S. Novel therapies in vasculitis. Expert Opin Investig Drugs 2001;10:1279-89   DOI   ScienceOn
24 Volpe JJ. Neurology of the newborn. 4th ed. Philadelia : WB saunders Co, 1995;314-69
25 Brewer GJ. Isolation and culture of adult rat hippocampal neurons. J Neurosci Meth 1997;71:143-55   DOI   ScienceOn
26 Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J. Bax promotes neuronal cell death and is down-regulated during the development of the nervous system. Development 1997;124:1239-49
27 Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998;101: 1992-9   DOI   ScienceOn
28 Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, et al. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 1997;272: 18518-21   DOI   ScienceOn
29 Allison AC, Eugui EM. Mycophenolate mofetil and its mechanism of action. Immunopharmacology. 2000;47:85-118   DOI   ScienceOn